Asahi Kasei Corp 2020 IR
The report outlines the Asahi Kasei Group's performance and strategic initiatives for fiscal 2019 under its medium-term management initiative 'Cs+ for Tomorrow 2021'. The company expanded its business in priority fields such as lithium-ion battery separators, automotive interior materials, and health care, notably through the acquisitions of Veloxis Pharmaceuticals and Cardiac Science. Despite a challenging economic environment leading to a decline in operating income, the group advanced its digital transformation and sustainability efforts, aiming for a 35% reduction in its greenhouse gas emissions index by fiscal 2030.
Company: Asahi Kasei Corp
Sector: Manufacturing
Country: Japan
Year: 2020
Type: IR
Pages: 31
Back to company
Asahi Kasei Corp
Corporate Report
The report outlines the Asahi Kasei Group's performance and strategic initiatives for fiscal 2019 under its medium-term management initiative 'Cs+ for Tomorrow 2021'. The company expanded its business in priority fields such as lithium-ion battery separators, automotive interior materials, and health care, notably through the acquisitions of Veloxis Pharmaceuticals and Cardiac Science. Despite a challenging economic environment leading to a decline in operating income, the group advanced its digital transformation and sustainability efforts, aiming for a 35% reduction in its greenhouse gas emissions index by fiscal 2030.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Apr 2019 - Mar 2020
Fiscal Year
2019
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees